Nature 442, 448-452 (27 July 2006) | doi:10.1038/nature04795; Received 25 January 2006; Accepted 11 April 2006; Published online 26 April 2006

Strategies for mitigating an influenza pandemic

Neil M. Ferguson1, Derek A. T. Cummings2, Christophe Fraser1, James C. Cajka3, Philip C. Cooley3 and Donald S. Burke2

Development of strategies for mitigating the severity of a new influenza pandemic is now a top global public health priority. Influenza prevention and containment strategies can be considered under the broad categories of antiviral, vaccine and non-pharmaceutical (case isolation, household quarantine, school or workplace closure, restrictions on travel) measures1. Mathematical models are powerful tools for exploring this complex landscape of intervention strategies and quantifying the potential costs and benefits of different options2, 3, 4, 5. Here we use a large-scale epidemic simulation6 to examine intervention options should initial containment6, 7 of a novel influenza outbreak fail, using Great Britain and the United States as examples. We find that border restrictions and/or internal travel restrictions are unlikely to delay spread by more than 2–3 weeks unless more than 99% effective. School closure during the peak of a pandemic can reduce peak attack rates by up to 40%, but has little impact on overall attack rates, whereas case isolation or household quarantine could have a significant impact, if feasible. Treatment of clinical cases can reduce transmission, but only if antivirals are given within a day of symptoms starting. Given enough drugs for 50% of the population, household-based prophylaxis coupled with reactive school closure could reduce clinical attack rates by 40–50%. More widespread prophylaxis would be even more logistically challenging but might reduce attack rates by over 75%. Vaccine stockpiled in advance of a pandemic could significantly reduce attack rates even if of low efficacy. Estimates of policy effectiveness will change if the characteristics of a future pandemic strain differ substantially from those seen in past pandemics.

  1. Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK
  2. Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, Maryland 21205, USA
  3. RTI International Inc., P.O. 12194, 3040 Cornwallis Rd, Research Triangle Park, North Carolina 27709, USA

Correspondence to: Neil M. Ferguson1 Correspondence and requests for materials should be addressed to N.M.F. (Email: neil.ferguson@imperial.ac.uk).


These links to content published by NPG are automatically generated.


Antiviral agents active against influenza A viruses

Nature Reviews Drug Discovery Review (01 Dec 2006)

See all 16 matches for Reviews


Touching base

Nature Genetics News and Views (01 Apr 2005)

Extra navigation